Company news
Genedx Holdings Corp. (NASDAQ:WGS) news
Every Genedx Holdings Corp. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
GeneDx Reports Second Quarter 2026 Financial Results
August 3, 2026
GeneDx to Report Second Quarter 2026 Financial Results on Monday, August 3, 2026
July 16, 2026
GeneDx to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
May 26, 2026
GeneDx Reports First Quarter 2026 Financial Results and Updates Full-Year Outlook
May 4, 2026
GeneDx to Report First Quarter 2026 Financial Results on Monday, May 4, 2026
April 13, 2026
Landmark Study Shows Average Cost Savings of $80,000 Per Child and Overall Improved Health Outcomes Following GeneDx Exome and Genome Tes...
March 11, 2026
GeneDx to Launch Genetic Testing Program with Zevra Therapeutics to Support Patients with Suspected Niemann-Pick Disease Type C
March 10, 2026
GeneDx to Present 18 Abstracts at ACMG 2026, Showcasing the Scale of GeneDx Infinity™ and Real-World Genomic Leadership
March 9, 2026
INSERTING and REPLACING GeneDx Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms Guidance for Full Year 2026
February 23, 2026
GeneDx Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms Guidance for Full Year 2026
February 23, 2026
TIME Names GeneDx CEO Katherine Stueland to the 2026 TIME100 Health List of the World’s Most Influential Leaders in Health
February 11, 2026
GeneDx to Report Fourth Quarter 2025 Financial Results on Monday, February 23, 2026
February 3, 2026
GeneDx Announces Preliminary 2025 Financial Results and Provides 2026 Guidance
January 12, 2026
GeneDx and Komodo Health Partner to Build the World’s Most Complete Longitudinal Rare Disease Dataset
January 8, 2026
GeneDx Announces GenomeDx Prenatal™, Expanding Industry-Leading Genomic Diagnosis Into Prenatal Care
January 7, 2026
GeneDx Appoints Dr. Linda Genen as Chief Medical Officer to Accelerate the Future of Genomic-First Care
January 6, 2026
GeneDx Leads Rare Disease Genomics with Unmatched Research and Clinical Impact in 2025
January 5, 2026
GeneDx to Present at the J.P. Morgan 2026 Healthcare Conference
December 30, 2025
JAMA (Journal of the American Medical Association) Recognizes GUARDIAN Newborn Genomic Screening Study Among Its Research of the Year
December 15, 2025
GeneDx to Showcase Advancements in Gene-Disease Discovery, Long-Read Sequencing and More at National Society of Genetic Counselors (NSGC)...
November 6, 2025
GeneDx to Participate in Upcoming Investor Conferences
November 4, 2025
GeneDx Reports Third Quarter 2025 Financial Results and Business Highlights
October 28, 2025
GeneDx Showcases Leadership in Genomic Newborn Screening at ICoNS 2025
October 22, 2025
GeneDx Granted FDA Breakthrough Device Designation for its ExomeDx™ and GenomeDx™ Testing
October 20, 2025
GeneDx Appoints Dr. Mimi Lee as Chief Precision Medicine Officer
October 14, 2025
GeneDx to Partner with Florida’s Sunshine Genetics Network, Launching Nation’s First State-Backed Genomic Newborn Screening Program
October 13, 2025
GeneDx to Launch Autism Partnership Program to Expand Access to Exome and Genome Testing, including Dedicated SHANK3 Program
October 9, 2025
GeneDx to Showcase Pioneering Research Findings at American Society of Human Genetics (ASHG) Annual Meeting
October 8, 2025
GeneDx to Report Third Quarter 2025 Financial Results on Tuesday, October 28, 2025
October 7, 2025
GeneDx Announces First U.S. National Genomic Newborn Screening Initiative Launched with $14.4 Million NIH Award
October 1, 2025
GeneDx Appoints Lisa Gurry as Chief Business Officer to Unlock Data and Information Growth
September 30, 2025
GeneDx Infinity™ Pioneers a New Era of Genetic Medicine with its Introduction at the American Academy of Pediatrics National Conference
September 25, 2025
GeneDx Appoints Visionary AI and Precision Medicine Leader Dr. Thomas Fuchs to Board of Directors
September 18, 2025
Seer Appoints Isaac Ro to its Board of Directors
September 2, 2025
OPKO Health Reports Second Quarter 2025 Business Highlights and Financial Results
July 31, 2025
GeneDx Reports Second Quarter 2025 Financial Results and Business Highlights
July 29, 2025
GeneDx to Report Second Quarter 2025 Financial Results on Tuesday, July 29, 2025
July 10, 2025
GeneDx Announces Publication of SeqFirst Study Demonstrating Need for First Tier Rapid Genomic Testing for Non-Critical Care Pediatric In...
June 25, 2025
GeneDx Announces American Academy of Pediatrics Recommends Exome and Genome Sequencing as First-Tier Tests for Children with Global Devel...
June 23, 2025
GeneDx Publishes Pioneering Vision for Applying AI to Genomics to Improve and Expedite Diagnosis of Genetic Disease at Scale
May 22, 2025
GeneDx Announces Completion of Fabric Genomics Acquisition
May 7, 2025
GeneDx Reports First Quarter 2025 Financial Results and Business Highlights
April 30, 2025
GeneDx to Acquire Fabric Genomics, Enabling Decentralized, AI-Powered Testing at Global Scale
April 16, 2025
GeneDx to Report First Quarter 2025 Financial Results on Wednesday, April 30, 2025
April 8, 2025
GeneDx Expands Commercial Footprint for Exome and Genome Testing with Inborn Errors of Immunity as a New Indication
April 3, 2025
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 20, 2025
Fast Company Recognizes GeneDx as One of the World's Most Innovative Companies
March 18, 2025
GeneDx Enhances the Power of its Interpretation Platform with Artificial Intelligence (AI) Powered Gene Ranker to Enable Faster and More ...
March 13, 2025
GeneDx to Showcase Key Research and Innovation at the 2025 American College of Medical Genetics (ACMG) Annual Meeting
March 13, 2025
GeneDx Expands Commercial Footprint for Exome and Genome Testing with Cerebral Palsy as a New Indication
March 4, 2025